Takaya Masahiko, Takigawa Kiyoto, Kawata Tetsuji
Medical office in Osaka Prison, 6-1, Tadei-Cho, Sakai City, Osaka, Japan.
Department of Neuropsychiatry, Kindai University Faculty of Medicine, 377-2, Onohigashi, Osaka Sayama, Osaka, Japan.
BMC Psychiatry. 2025 May 22;25(1):519. doi: 10.1186/s12888-025-06966-2.
In Japan, drug addiction recovery guidance and social reintegration programs are implemented for eligible inmates in many prisons. However, methamphetamine addiction, especially among those with a history of thinner inhalation, often seems not to be adequately addressed in addiction treatment programs. The comorbidities of substance use disorders may be generally overlooked. This study aimed to provide valuable data for guiding the development of programs to combat drug addiction and support social reintegration for inmates. The first step of this study sought to determine the association between history of daily/regular methamphetamine use and use of other substances as well as the relationship between methamphetamine use and sociodemographic background.
This retrospective study included 470 consecutive inmates whose data were obtained and who consulted a certified psychiatrist. Chi-square tests and paired t-tests were used for the analysis. Furthermore, a multinominal regression analysis was performed.
Our findings revealed that the history of daily/regular methamphetamine use was significantly associated with the history of psychiatric consultation, sexually transmitted infections, daily/regular thinner inhalation, and daily/regularly tobacco smoking. Moreover, daily/regular thinner inhalation was initiated at a significantly younger age than methamphetamine use. In addition, tobacco smoking was initiated at a significantly younger age than methamphetamine use.
The present study suggested that a history of daily/regular thinner inhalation and daily/regular tobacco smoking may serve as potential risk factors for the development of daily/regular methamphetamine use. Furthermore, these findings highlight the significant association between thinner or nicotine addiction and subsequent methamphetamine addiction. These results may provide valuable insights for supporting and protecting inmates with methamphetamine addiction as well as individuals at risk.
Not applicable.
在日本，许多监狱为符合条件的囚犯实施了药物成瘾康复指导和社会重新融入计划。然而，甲基苯丙胺成瘾，尤其是在有吸入稀释剂史的人群中，在成瘾治疗计划中似乎常常没有得到充分解决。物质使用障碍的共病情况可能普遍被忽视。本研究旨在提供有价值的数据，以指导制定打击药物成瘾和支持囚犯社会重新融入的计划。本研究的第一步旨在确定每日/定期使用甲基苯丙胺的历史与其他物质使用之间的关联，以及甲基苯丙胺使用与社会人口背景之间的关系。
这项回顾性研究纳入了470名连续的囚犯，他们的数据已获取且咨询过一名认证精神科医生。采用卡方检验和配对t检验进行分析。此外，还进行了多项回归分析。
我们的研究结果显示，每日/定期使用甲基苯丙胺的历史与精神科咨询史、性传播感染、每日/定期吸入稀释剂以及每日/定期吸烟显著相关。此外，每日/定期吸入稀释剂开始的年龄显著低于甲基苯丙胺使用开始的年龄。另外，吸烟开始的年龄也显著低于甲基苯丙胺使用开始的年龄。
本研究表明，每日/定期吸入稀释剂和每日/定期吸烟的历史可能是每日/定期使用甲基苯丙胺发展的潜在风险因素。此外，这些发现突出了稀释剂或尼古丁成瘾与随后的甲基苯丙胺成瘾之间的显著关联。这些结果可能为支持和保护甲基苯丙胺成瘾囚犯以及有风险的个人提供有价值的见解。
不适用。
